Stampacchia Otello — SEC insider filings
SEC reporting owner CIK 1361712. 72 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers the 50 most recent of 72 filings on record, filed 2021-02-11 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 4 filings — 2,659,601 shares, $45,749,919 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 178 legs across 34 filings — 933,924 shares, $42,662,135 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: purchase of 875,000 shares @ $17.00 ($14,875,000) in WINDWARD BIO GROUP AG, filed 2026-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Morphic Holding, Inc. (MORF) | Director | 23 | — | 154 legs · 574,716 sh · $32,470,894 | — |
| WINDWARD BIO GROUP AG (WWB) | Director | 3 | 2 legs · 1,750,000 sh · $29,750,000 | — | 9 |
| Replimune Group, Inc. (REPL) | 10% owner | 12 | — | 24 legs · 359,208 sh · $10,191,242 | 3 |
| ImageneBio, Inc. (IMA) | Director | 7 | 1 leg · 267,556 sh · $7,999,924 | — | 11 |
| Lexeo Therapeutics, Inc. (LXEO) | 10% owner | 1 | 1 leg · 454,545 sh · $4,999,995 | — | 4 |
| Theseus Pharmaceuticals, Inc. (THRX) | — | 1 | 1 leg · 187,500 sh · $3,000,000 | — | 2 |
| Nuvation Bio Inc. (NUVB) | 10% owner | 1 | — | — | 3 |
| Kronos Bio, Inc. (KRON) | Director | 2 | — | — | 2 |
Insider filings — Stampacchia Otello
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | WINDWARD BIO GROUP AG (WWB) | Purchase (P): 875,000 @ $17 · Purchase (P): 875,000 @ $17 · Conversion (C): 1,262,628 · Conversion (C): 1,262,626 · Conversion (C): 531,632 · Conversion (C): 531,634 · +4 more | EDGAR |
| 2026-11-16 | 4 | WINDWARD BIO GROUP AG (WWB) | Grant/award (A): 22,675 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 3 | WINDWARD BIO GROUP AG (WWB) | Holdings only — no transactions reported | EDGAR |
| 2026-06-18 | 4 | ImageneBio, Inc. (IMA) | Grant/award (A): 15,600 (derivative) @ $0 | EDGAR |
| 2025-07-30 | 4 | ImageneBio, Inc. (IMA) | Option exercise (M): 379 · Purchase (P): 267,556 @ $29.90 · Option exercise (M): 17,520 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 17,520 (derivative) @ $0 | EDGAR |
| 2023-11-09 | 4 | Lexeo Therapeutics, Inc. (LXEO) jointly with Omega Fund VI, L.P., Omega Fund VI GP, L.P., Omega Fund VI GP Manager, Ltd., Nessi Claudio, Paster Anne-Mari | Conversion (C): 1,415,865 · Conversion (C): 287,213 · Purchase (P): 454,545 @ $11 · Conversion (C): 14,999,999 (derivative) · Conversion (C): 2,615,533 (derivative) | EDGAR |
| 2023-06-13 | 4 | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 17,520 (derivative) @ $0 | EDGAR |
| 2022-06-29 | 4 | Kronos Bio, Inc. (KRON) | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 13,419 (derivative) @ $0 | EDGAR |
| 2022-03-16 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd. | Option exercise (M): 16,500 @ $9.78 · Sale (S): 16,500 @ $15.42 · Sale (S): 45,000 @ $15.64 · Sale (S): 6,238 @ $15.31 · Sale (S): 38,762 @ $15.55 · Option exercise (M): 16,500 (derivative) @ $0 | EDGAR |
| 2021-12-23 | 4 | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 13,419 (derivative) @ $0 | EDGAR |
| 2021-11-23 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd. | Sale (S): 34,845 @ $34.54 · Sale (S): 417 @ $34.80 · Sale (S): 10,162 @ $34.70 | EDGAR |
| 2021-11-18 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd. | Sale (S): 153 @ $33.50 · Sale (S): 2,441 @ $33.50 | EDGAR |
| 2021-11-18 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd. | Sale (S): 153 @ $33.50 · Sale (S): 2,441 @ $33.50 | EDGAR |
| 2021-11-16 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd. | Sale (S): 23,235 @ $33.66 · Sale (S): 782 @ $33.66 | EDGAR |
| 2021-11-12 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd. | Sale (S): 11 @ $33.50 · Sale (S): 18,279 @ $33.61 | EDGAR |
| 2021-11-10 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd. | Sale (S): 3,817 @ $33.53 · Sale (S): 7,537 @ $33.73 | EDGAR |
| 2021-11-08 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd. | Sale (S): 25,225 @ $33.58 · Sale (S): 5,790 @ $33.50 | EDGAR |
| 2021-10-14 | 4 | Theseus Pharmaceuticals, Inc. (THRX) jointly with Omega Fund VI, L.P., Omega Fund VI GP Manager, Ltd., Nessi Claudio, Paster Anne-Mari | Conversion (C): 523,979 · Purchase (P): 187,500 @ $16 · Conversion (C): 693,152 (derivative) | EDGAR |
| 2021-09-27 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd. | Sale (S): 12,171 @ $33.58 | EDGAR |
| 2021-09-20 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd. | Sale (S): 5,537 @ $32.55 · Sale (S): 78,998 @ $32.88 · Sale (S): 15,465 @ $33.71 | EDGAR |
| 2021-06-23 | 4 | Kronos Bio, Inc. (KRON) | Grant/award (A): 20,600 (derivative) @ $0 | EDGAR |
| 2021-05-03 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 3,826 @ $53.37 · Sale (S): 2,731 @ $54.51 · Sale (S): 1,114 @ $55.23 · Sale (S): 1,358 @ $54.26 · Sale (S): 5,274 @ $55.04 · Sale (S): 2,855 @ $55.73 | EDGAR |
| 2021-04-29 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 2,589 @ $54.60 · Sale (S): 4,417 @ $55.62 · Sale (S): 332 @ $56.28 · Sale (S): 1,376 @ $55.36 · Sale (S): 1,990 @ $55.96 | EDGAR |
| 2021-04-27 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 3,132 @ $55.11 · Sale (S): 3,838 @ $55.76 · Sale (S): 1,701 @ $56.50 · Sale (S): 1 @ $57.43 · Sale (S): 1,335 @ $55.54 · Sale (S): 2,538 @ $56.71 · +1 more | EDGAR |
| 2021-04-23 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 1,929 @ $53.76 · Sale (S): 109 @ $55.15 · Sale (S): 1,991 @ $56.74 · Sale (S): 3,523 @ $57.48 · Sale (S): 2,577 @ $56.34 · Sale (S): 5,329 @ $57.08 · +3 more | EDGAR |
| 2021-04-21 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 7,272 @ $54.06 · Sale (S): 809 @ $54.66 · Sale (S): 5,343 @ $54.07 · Sale (S): 4,374 @ $54.88 · Sale (S): 76 @ $55.54 | EDGAR |
| 2021-04-19 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 3,667 @ $55.16 · Sale (S): 4,331 @ $56.10 · Sale (S): 2,828 @ $57.15 · Sale (S): 355 @ $58.11 · Sale (S): 3,846 @ $54.37 · Sale (S): 2,719 @ $55.36 | EDGAR |
| 2021-04-15 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 1,758 @ $56.70 · Sale (S): 4,879 @ $57.61 · Sale (S): 367 @ $58.25 · Sale (S): 4,097 @ $55.88 · Sale (S): 2,055 @ $56.95 · Sale (S): 3,716 @ $58.08 · +1 more | EDGAR |
| 2021-04-13 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 3,126 @ $58.13 · Sale (S): 5,229 @ $59.19 · Sale (S): 1,830 @ $60.05 · Sale (S): 35 @ $61.41 · Sale (S): 6,149 @ $56.84 · Sale (S): 7,735 @ $57.46 · +1 more | EDGAR |
| 2021-04-09 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 6,277 @ $60.51 · Sale (S): 5,172 @ $61.01 · Sale (S): 4,745 @ $60.48 · Sale (S): 10,491 @ $60.98 | EDGAR |
| 2021-04-07 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 3,079 @ $61.05 · Sale (S): 3,918 @ $61.79 · Sale (S): 1,354 @ $63.13 · Sale (S): 1,192 @ $64.71 · Sale (S): 7,273 @ $60.93 · Sale (S): 3,543 @ $61.48 · +1 more | EDGAR |
| 2021-04-05 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd., Paster Anne-Mari | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2021-04-02 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 5,112 @ $62.45 · Sale (S): 11,560 @ $63.34 · Sale (S): 112 @ $63.97 · Sale (S): 942 @ $62.89 · Sale (S): 2,064 @ $64.44 · Sale (S): 9,303 @ $65.19 · +1 more | EDGAR |
| 2021-04-01 | 4 | Ikena Oncology, Inc. (IKNA) | Conversion (C): 1,799,123 · Grant/award (A): 450,000 @ $16 · Grant/award (A): 12,870,933 (derivative) @ $1.40 · Conversion (C): 12,870,933 (derivative) | EDGAR |
| 2021-03-31 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 7,795 @ $58.24 · Sale (S): 5,551 @ $59.12 · Sale (S): 2,814 @ $60.06 · Sale (S): 8 @ $60.88 · Sale (S): 2,408 @ $58.18 · Sale (S): 581 @ $59.16 · +4 more | EDGAR |
| 2021-03-29 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 4,004 @ $56.28 · Sale (S): 8,820 @ $57.24 · Sale (S): 11,257 @ $58.21 · Sale (S): 4,087 @ $59.02 · Sale (S): 6,372 @ $60.43 · Sale (S): 416 @ $60.86 · +3 more | EDGAR |
| 2021-03-25 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 1,751 @ $60.81 · Sale (S): 9,236 @ $61.94 · Sale (S): 6,912 @ $62.70 · Sale (S): 1,444 @ $63.66 · Sale (S): 6,255 @ $57.05 · Sale (S): 8,280 @ $58.18 · +4 more | EDGAR |
| 2021-03-23 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 2,919 @ $61.92 · Sale (S): 5,026 @ $63.01 · Sale (S): 5,836 @ $64 · Sale (S): 2,848 @ $64.69 · Sale (S): 1,751 @ $63.98 · Sale (S): 5,996 @ $64.99 · +1 more | EDGAR |
| 2021-03-19 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 7,301 @ $63.72 · Sale (S): 8,087 @ $64.59 · Sale (S): 993 @ $65.26 · Sale (S): 3,235 @ $63 · Sale (S): 15,154 @ $64.02 · Sale (S): 1,083 @ $64.58 | EDGAR |
| 2021-03-17 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 10,341 @ $63.97 · Sale (S): 4,004 @ $64.78 · Sale (S): 6,620 @ $66.06 · Sale (S): 10,825 @ $66.94 · Sale (S): 2,630 @ $67.96 · Sale (S): 2,112 @ $69.13 · +6 more | EDGAR |
| 2021-03-01 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 7,424 @ $33.46 · Sale (S): 2,013 @ $34.39 · Sale (S): 242 @ $35.32 · Sale (S): 2,376 @ $32.87 · Sale (S): 5,458 @ $34.28 · Sale (S): 7,808 @ $35.27 · +4 more | EDGAR |
| 2021-02-25 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 5,498 @ $33.75 · Sale (S): 2,052 @ $34.36 · Sale (S): 567 @ $34.27 · Sale (S): 2,431 @ $34.89 | EDGAR |
| 2021-02-23 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 2,025 @ $34.82 · Sale (S): 1,871 @ $36.12 · Sale (S): 540 @ $36.50 · Sale (S): 5,638 @ $34.80 · Sale (S): 785 @ $35.72 | EDGAR |
| 2021-02-19 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 7,262 @ $35.93 · Sale (S): 7,966 @ $34.83 · Sale (S): 928 @ $35.76 | EDGAR |
| 2021-02-17 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 1,588 @ $37.47 · Sale (S): 776 @ $38.21 · Sale (S): 4,863 @ $36.42 · Sale (S): 1,162 @ $37.25 | EDGAR |
| 2021-02-12 | 4 | Morphic Holding, Inc. (MORF) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd. | Sale (S): 5,022 @ $37.34 · Sale (S): 1,046 @ $38.49 · Sale (S): 3,988 @ $37.76 · Sale (S): 17 @ $38.08 | EDGAR |
| 2021-02-12 | 4 | Nuvation Bio Inc. (NUVB) jointly with Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd., Nessi Claudio, Paster Anne-Mari, DOIG MICHELLE | Conversion (C): 8,130,097 · Grant/award (A): 500,000 @ $10 · Conversion (C): 8,130,097 (derivative) @ $0 | EDGAR |
| 2021-02-11 | 4 | Replimune Group, Inc. (REPL) jointly with Omega Fund IV, L.P., Omega Fund IV GP, L.P., Omega Fund IV G.P. Manager, Ltd. | Sale (S): 5,249 @ $45 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1361712 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs